Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2024 Earnings Presentation

15 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Jul 25, 2024

  1. Slide 1: H1 Conference Call

    H1 Conference Call Drägerwerk AG & Co. KGaA July 25, 2024, Lübeck

  2. Slide 2: Disclaimer

    Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future

  3. Slide 3: Agenda

    Agenda — 01 Dräger Business Highlights 02 Financials H1 2024 03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 3

  4. Slide 4: Dräger Business Highlights

    01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4

  5. Slide 5: H1 2024 Highlights

    H1 2024 On track to Earnings above prior year annual forecast despite lower net sales Highlights Solid business performance: net sales almost at high prior-year level; earnings up due to solid Technology for Life remains high: business performance and one- time effects Net sales EBIT order intake ab

  6. Slide 6: Financials H1 2024

    02 Financials H1 2024 Drägerwerk AG & Co. KGaA 6

  7. Slide 7: Business development Group

    Business development Group Order entry (€ million) 6M 2023 6M 2024 Change (fx-adj.) — Net sales (€ million) Germany EMEA 373.1 616.9 385.7 613.7 +3.4 -0.6 +2.0% -0.3% Americas 305.0 349.5 +13.7 fx-adj fx-adj +1.7% -0.8% APAC 301.7 255.5 -12.1 nominal nominal 1,532 1,520 Total 1,596.6 1,604.3 +0.9 77

  8. Slide 8: Business development Medical

    Business development Medical Order entry (€ million) 6M 2023 6M 2024 Change (fx-adj.) — Net sales (€ million) Germany EMEA 202.5 327.4 201.0 307.7 -0.7 -6.0 -2.3% -6.5% Americas 187.1 235.6 +24.5 fx-adj fx-adj -2.7% -7.1% APAC 200.5 155.7 -19.0 nominal nominal 911 Total 917.5 900.1 -1.5 846 441 429

  9. Slide 9: Business development Safety

    Business development Safety Order entry (€ million) 6M 2023 6M 2024 Change (fx-adj.) — Net sales (€ million) Germany EMEA 170.6 289.4 184.6 306.0 +8.2 +5.5 +7.9% +8.8% Americas 117.9 113.9 -3.4 fx-adj fx-adj +7.7% +8.5% APAC 101.2 99.8 +1.5 nominal nominal 674 Total 679.1 704.3 +4.1 622 330 356 • Or

  10. Slide 10: Key figures

    Key figures 6M 2024 6M 2023 Change € million € million % Cashflow (from operating activities) -5.5 -7.3 +25.0 Investments 52.6 62.1 -15.2 Cash and cash equivalents1 190.7 185.4 +2.9 Net financial debt1 271.2 326.7 -17.0 Net financial debt1 / EBITDA2 0.9 1.5 Capital employed 1 1,600.4 1,611.4 -0.7 RO

  11. Slide 11: Outlook FY 2024

    03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 11

  12. Slide 12: Outlook

    Outlook Results achieved Forecast for Current forecast for for fiscal year 2023 fiscal year 2024 fiscal year 2024 Net sales (net of currency effects) 13.1% 1.0 to 5.0% lower half of range Gross margin 43.3% 43.0 to 45.0% confirmed EBIT margin 4.9% 2.5 to 5.5% upper half of range Dräger Value Added (

  13. Slide 13: Questions & Answers

    Questions & Answers Drägerwerk AG & Co. KGaA 13

  14. Slide 14: Financial calendar

    Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 7, 2024 Annual Report 2023 Conference call April 25, 2024 Report for the first three months 2024 Conference c

  15. Slide 15: Thank you

    Thank you Thomas Fischler Nikolaus Hammerschmidt Head of Treasury & Investor Relations Investor Relations Manager Moislinger Alle 53-55 Moislinger Alle 53-55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel. +49 451 882 2685 Tel. +49 451 882 8903 Mail: thomas.fischler@draeger.com Mail: nikolaus.hamme

Drägerwerk AG & Co. KGaA — H1 2024 Earnings Presentation on 6ix